Related Experiment Video
Updated: Aug 30, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Melatonin supplementation for severe and intractable sleep disturbance in young people with genetically determined
1Department of Clinical Developmental Sciences, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. j.turk@sghms.ac.uk
Insights
Severe sleep disturbance is common in children with developmental disabilities. Melatonin may be a safe and effective addition to behavioral strategies for managing this challenging symptom.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Sleep Medicine
Background:
- Serious childhood developmental disabilities are prevalent and often have genetic origins.
- Challenging behaviors, particularly severe sleep disturbance, are frequent comorbidities.
- Sleep disturbance negatively impacts development, academics, and family well-being.
Purpose of the Study:
- To review the prevalence and severity of sleep disturbance in children with severe neurodevelopmental disabilities.
- To evaluate the role of medications as an adjunct to behavioral interventions.
- To assess the efficacy and safety of melatonin for sleep induction.
Main Methods:
- Literature review of studies on sleep disturbance in neurodevelopmental disabilities.
- Analysis of evidence for pharmacological interventions, focusing on melatonin.
- Synthesis of data on the benefits and risks of medication in conjunction with social and behavioral strategies.
Main Results:
- Sleep disturbance is a significant and common issue in this population.
- Behavioral approaches (sleep hygiene) are not always effective.
- Melatonin shows potential as a safe and useful adjunct for managing severe sleep disturbance.
Conclusions:
- Melatonin can be a beneficial and safe addition to existing treatments for sleep problems in children with severe neurodevelopmental disabilities.
- Careful monitoring is essential when using medication.
- A multimodal approach combining medication with psychological and social strategies is recommended.
Abstract:
Serious childhood developmental disabilities are common, and are debilitating for the individual and their family. Increasingly these are being shown to have genetic bases. Associated challenging behaviours are frequent, one of the commonest being severe and intractable sleep disturbance. This is associated with daytime behaviour problems, poor developmental and academic progress, and substantial familial psychopathology. Social and behavioural approaches ("sleep hygiene" measures) have, to an extent, revolutionised management; however, many individuals remain unresponsive. Modern medications therefore play increasingly important complementary roles in conjunction with psychological, educational, and social strategies. This paper reviews evidence for the frequency and severity of sleep disturbance in children and young people with severe intractable neurodevelopmental disabilities. The potential benefits of judicious and carefully monitored use of medication are described, with a focus on the importance of melatonin as a sleep inducer. It is concluded that melatonin is a potentially useful and safe adjunct to psychological and social approaches for severe sleep disturbance in this client group.
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...

